TevaTeva Pharmaceutical Industries Limited, Netanya, Israel
Teva Pharmaceutical Industries Ltd. is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. We deliver high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs. We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated Research and Development (R&D) function, strong operational base and global infrastructure and scale. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 45,000 professionals, committed to improving the lives of millions of patients.
Role in AIMS-2-TRIALS
Teva is contributing to the AIMS-2-TRIALS by participating in the development of a global communication and dissemination strategy covering topics such as ethics, new therapeutic approaches, and the outcomes of the AIMS-2-TRIALS consortium.
Through Teva’s collaboration with Dr Evan Elliott at the Bar Ilan Medical School in Safed, Israel (http://medweb.md.biu.ac.il/research/evan-elliott/), we are able to reach a wide network of people on the autism spectrum, their families and caregivers, and the Israeli autism research community. Teva and Dr Elliott’s team will provide diverse educational materials for parents and caregivers of people with autism spectrum disorders (ASD) in multiple languages including English, Hebrew and Arabic. Teva will also support a research conference led by Dr Elliott’s team for patients, caregivers and clinicians to further disseminate the latest research findings in autism research and to support communication between the patient and caregiver communities and the autism researchers. Teva will help disseminate updates about the consortium’s activities to diverse stakeholders in Israel, including individuals with ASD and their families and caregivers, clinicians, and autism researchers.
Assoc. Director Academic Affairs & Networks
VP Non-clinical development